跳至主要内容
临床试验/NCT00241280
NCT00241280已完成不适用

Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).

Johnson & Johnson Vision Care, Inc.50 个研究点 分布在 1 个国家目标入组 504 人开始时间: 2005年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
504
试验地点
50
主要终点
Rate of Contact Lens Related Serious and Significant Events (SSE)

研究概览

简要总结

Study in the US intended to evaluate the safety and effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) contact lens for use on an extended-wear basis for up to 7 days (6 nights).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The subject must be at least 18 years of age.
  • The subject must read and sign the statement of informed consent and be provided with a copy of the form.
  • Minimum of 7 days of successful lens wear
  • Contact lens prescription requiring between -1.00 to -6.00 D spherical power
  • Less than 1.00 D of astigmatism in either eye

排除标准

  • 未提供

研究组 & 干预措施

Control

Active Comparator

etafilcon A contact lens being worn 7 days/6 nights.

干预措施: etafilcon A (Device)

Test

Experimental

galyfilcon A contact lens being worn 7 days/6 nights.

干预措施: galyfilcon A (Device)

结局指标

主要结局

Rate of Contact Lens Related Serious and Significant Events (SSE)

时间窗: Throughout the duration of the study (1 Year)

The number of Contact-Lens related Serious and Significant Adverse Events were reported for each study lens. The incidence of rates of contact-lens related SSEs were calculated as (# of subjects that experienced an event)/(total # subjects). If there were multiple diagnostic findings, the event was categorized under the highest event level diagnostic.

Monocular Contact Lens Snellen Visual Acuity Worse Than 20/40

时间窗: Follow-up Visits- 24 hr, 1, 4, 12, 24,36, and 52 weeks

Percentage of subject eyes reported with visual acuity worse than 20/40 at each study visit.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (50)

Loading locations...

相似试验